Detalhe da pesquisa
1.
Integrating novel agents into the treatment of advanced mycosis fungoides and Sézary syndrome.
Blood
; 141(7): 695-703, 2023 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36379025
2.
Resistance to mogamulizumab is associated with loss of CCR4 in cutaneous T-cell lymphoma.
Blood
; 139(26): 3732-3736, 2022 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35436328
3.
Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC.
Blood
; 140(5): 419-437, 2022 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34758074
4.
Identifying and addressing unmet clinical needs in primary cutaneous B-cell lymphoma: A consensus-based paper from an ad-hoc international panel.
Hematol Oncol
; 42(1): e3215, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37649350
5.
Radiation Therapy for Primary Cutaneous Gamma Delta Lymphoma Prior to Stem Cell Transplantation.
Cancer Invest
; : 1-8, 2023 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-33899635
6.
Identifying unmet needs and challenges in the definition of a plaque in mycosis fungoides: An EORTC-CLTG/ISCL survey.
J Eur Acad Dermatol Venereol
; 37(4): 680-688, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36606565
7.
T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 20(3): 285-308, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35276674
8.
NCCN Guidelines Insights: T-Cell Lymphomas, Version 1.2021.
J Natl Compr Canc Netw
; 18(11): 1460-1467, 2020 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33152703
9.
NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020.
J Natl Compr Canc Netw
; 18(5): 522-536, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32380458
10.
IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial.
Lancet Oncol
; 20(8): 1160-1170, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31253572
11.
Clinical characteristics, treatment patterns, and outcomes of cytotoxic cutaneous T-cell lymphomas.
Am J Hematol
; 99(5): 985-988, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38391088
12.
Role of imaging in low-grade cutaneous B-cell lymphoma presenting in the skin.
J Am Acad Dermatol
; 81(4): 970-976, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30703460
13.
Utility of CD30, Ki-67, and p53 in assisting with the diagnosis of mycosis fungoides with large cell transformation.
J Cutan Pathol
; 46(1): 33-43, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30328119
14.
Measurement of Quality of Life in Patients with Mycosis Fungoides/Sézary Syndrome Cutaneous T-Cell Lymphoma: Development of an Electronic Instrument.
J Med Internet Res
; 21(1): e11302, 2019 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30617041
15.
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial.
Lancet Oncol
; 19(9): 1192-1204, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30100375
16.
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial.
Lancet
; 390(10094): 555-566, 2017 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28600132
17.
NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018.
J Natl Compr Canc Netw
; 16(2): 123-135, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29439173
18.
Primary cutaneous aggressive epidermotropic cytotoxic T-cell lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomas.
Mod Pathol
; 30(5): 761-772, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28128277
19.
Phase 1/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma.
Blood
; 125(12): 1883-9, 2015 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-25605368
20.
NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 1.2017.
J Natl Compr Canc Netw
; 15(3): 293-311, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28275031